APA (7th ed.) Citation

Wu, C., Xu, Q., Wang, H., Tu, B., Zeng, J., Zhao, P., . . . Huang, Y. (2023). Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]. Acta pharmaceutica Sinica. B, 13(11), 4664-4666. https://doi.org/10.1016/j.apsb.2023.08.007

Chicago Style (17th ed.) Citation

Wu, Canhao, Qin Xu, Huiyuan Wang, Bin Tu, Jiaxin Zeng, Pengfei Zhao, Mingjie Shi, Hong Qiu, and Yongzhuo Huang. "Author Correction to “Neutralization of SARS-CoV-2 Pseudovirus Using ACE2-engineered Extracellular Vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]." Acta Pharmaceutica Sinica. B 13, no. 11 (2023): 4664-4666. https://doi.org/10.1016/j.apsb.2023.08.007.

MLA (9th ed.) Citation

Wu, Canhao, et al. "Author Correction to “Neutralization of SARS-CoV-2 Pseudovirus Using ACE2-engineered Extracellular Vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]." Acta Pharmaceutica Sinica. B, vol. 13, no. 11, 2023, pp. 4664-4666, https://doi.org/10.1016/j.apsb.2023.08.007.